热门资讯> 正文
安进将再斥资3亿美元用于美国制造业
2026-05-05 02:42
- Amgen (AMGN) said it is boosting its already significant investment to add to its US manufacturing capacity through an additional $300M.
- The large biopharma is specifically expanding an existing biologic facility in Juncos, Puerto Rico.
- Since 2025, Amgen has made a $900M manufacturing investment in Ohio and a prior $650M investment in Puerto Rico.
More on Amgen
- Amgen Inc. (AMGN) Q1 2026 Earnings Call Transcript
- Amgen Inc. 2026 Q1 - Results - Earnings Call Presentation
- Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs
- Amgen raises 2026 guidance to $37.1B-$38.5B revenue and $21.70-$23.10 non-GAAP EPS while expanding MariTide Phase III switching studies
- Amgen achieves Q1 double beat; 2026 guidance ranges meet expectations
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。